Convincing evidence supports that about two-thirds of PSA results are false-positives for PCa [4,5,6], which may lead to overdiagnosis, overtreatment, and adverse effects that the treatment may cause [7]. This evidence concerns the gene KLK3 and posterior cortical atrophy.